CA1003770A - Enzyme amplification assay - Google Patents

Enzyme amplification assay

Info

Publication number
CA1003770A
CA1003770A CA141,808A CA141808A CA1003770A CA 1003770 A CA1003770 A CA 1003770A CA 141808 A CA141808 A CA 141808A CA 1003770 A CA1003770 A CA 1003770A
Authority
CA
Canada
Prior art keywords
amplification assay
enzyme amplification
enzyme
assay
amplification
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA141,808A
Other languages
English (en)
Other versions
CA141808S (en
Inventor
Kenneth E. Rubenstein
Edwin F. Ullman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syva Co
Original Assignee
Syva Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syva Co filed Critical Syva Co
Application granted granted Critical
Publication of CA1003770A publication Critical patent/CA1003770A/en
Expired legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/948—Sedatives, e.g. cannabinoids, barbiturates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/535—Production of labelled immunochemicals with enzyme label or co-enzymes, co-factors, enzyme inhibitors or enzyme substrates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/946—CNS-stimulants, e.g. cocaine, amphetamines
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9486—Analgesics, e.g. opiates, aspirine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CA141,808A 1971-05-14 1972-05-10 Enzyme amplification assay Expired CA1003770A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14360971A 1971-05-14 1971-05-14

Publications (1)

Publication Number Publication Date
CA1003770A true CA1003770A (en) 1977-01-18

Family

ID=22504809

Family Applications (1)

Application Number Title Priority Date Filing Date
CA141,808A Expired CA1003770A (en) 1971-05-14 1972-05-10 Enzyme amplification assay

Country Status (12)

Country Link
JP (1) JPS5327763B1 (de)
BR (1) BR7202989D0 (de)
CA (1) CA1003770A (de)
CH (1) CH553410A (de)
DE (1) DE2223385C3 (de)
ES (1) ES402720A1 (de)
FR (1) FR2139505A5 (de)
GB (2) GB1401298A (de)
IL (1) IL39323A (de)
IT (1) IT972332B (de)
NL (1) NL170564C (de)
SE (1) SE403190B (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1981001414A1 (en) * 1979-11-19 1981-05-28 Charles Hospital Dev An improved method of non homogenous enzyme immunoassay

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1028643A (en) * 1975-02-20 1978-03-28 Judith I. Blakemore Polylodothyronine immunoassay
US4104367A (en) * 1976-10-13 1978-08-01 Hoffmann-La Roche Inc. Radioimmunoassay for methadone
US4220450A (en) * 1978-04-05 1980-09-02 Syva Company Chemically induced fluorescence immunoassay
DE2923139A1 (de) * 1979-06-07 1980-12-18 Boehringer Mannheim Gmbh Verfahren zur herstellung von immunologisch aktiven enzymmarkierten konjugaten
GB2120785A (en) * 1982-05-26 1983-12-07 Celltech Ltd Enzyme immunoassay
GB8407736D0 (en) * 1984-03-26 1984-05-02 Univ London Detecting specific polynucleotide sequences
IT1178788B (it) * 1984-12-21 1987-09-16 Sclavo Spa Metodo immunoenzimatico per la determinazione di analiti e composizione adatti allo scopo
US4833073A (en) * 1987-01-27 1989-05-23 Hoffmann-La Roche Inc. Immunoassay for tetrahydrocannabinol metabolites
US5374524A (en) * 1988-05-10 1994-12-20 E. I. Du Pont De Nemours And Company Solution sandwich hybridization, capture and detection of amplified nucleic acids
US5137804A (en) * 1988-05-10 1992-08-11 E. I. Du Pont De Nemours And Company Assay device and immunoassay
US5196306A (en) * 1989-03-29 1993-03-23 E. I. Du Pont De Nemours And Company Method for the detection or quantitation of an analyte using an analyte dependent enzyme activation system
EP2418492B1 (de) * 2010-08-10 2018-10-10 Randox Laboratories Ltd. Immunoreagens für Meprobamate

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1981001414A1 (en) * 1979-11-19 1981-05-28 Charles Hospital Dev An improved method of non homogenous enzyme immunoassay

Also Published As

Publication number Publication date
IT972332B (it) 1974-05-20
ES402720A1 (es) 1976-12-01
DE2223385A1 (de) 1973-01-04
NL170564B (nl) 1982-06-16
NL7206434A (de) 1972-11-16
CH553410A (fr) 1974-08-30
IL39323A (en) 1975-08-31
GB1401297A (en) 1975-07-16
FR2139505A5 (de) 1973-01-05
DE2223385C3 (de) 1984-10-25
IL39323A0 (en) 1972-06-28
BR7202989D0 (pt) 1973-11-01
DE2223385B2 (de) 1979-02-22
NL170564C (nl) 1982-11-16
GB1401298A (en) 1975-07-16
JPS5327763B1 (de) 1978-08-10
SE403190B (sv) 1978-07-31

Similar Documents

Publication Publication Date Title
CA978457A (en) Enzyme electrode
CA1020894A (en) Enzyme compositions
AU469805B2 (en) Enzymes
CA978113A (en) Enzyme stabilization
CA943810A (en) Cheese manufacture using proteolytic enzymes
ZA72619B (en) Enzymes
CA1003770A (en) Enzyme amplification assay
AU3358471A (en) Enzymes
CA1011671A (en) Immobilized enzymes
CA986441A (en) Enzyme treatment
AU3504771A (en) Enzyme preparations
CA946837A (en) Enzyme inhibitor
CA953377A (en) Line amplifier
AU468613B2 (en) Improved precipitating solution for & amylase assay
CA976098A (en) Water-insoluble enzyme products
CA984015A (en) Isolation amplifier
CA946836A (en) Enzyme inhibitor
AU461012B2 (en) Enzymes
CA850073A (en) Enzyme manufacture
AU430886B2 (en) Torque amplifying direct powershift
CA880529A (en) Class d amplifiers
CA849492A (en) Proteolytic enzymes
CA985607A (en) Enzyme combination
CA869134A (en) Amplifiers employing transistors
CA960166A (en) Enzyme treatment